✦ LIBER ✦

28 Kinase bypass: A new strategy for antl-HIV drug design

✍ Scribed by C. McGuigan; D. Kinchington; M.F. Wang; S.R. Nicholls; C. Nickson; S. Galpin; D.J. Jeffries; T.J. O'Connor

Book ID: 118393097
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 51 KB
Volume: 20
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(93)90406-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Restrained molecular dynamics simulation

Restrained molecular dynamics simulations of HIV-1 protease: The first step in validating a new target for drug design

✍ Alexander L. Perryman; Jung-Hsin Lin; J. Andrew McCammon 📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 804 KB

## Abstract To test the anticorrelated relationship that was recently displayed in conventional molecular dynamics (MD) simulations, several different restrained MD simulations on a wild type and on the V82F/I84V drug‐resistant mutant of HIV‐1 protease were performed. This anticorrelated relationsh

A new approach for an HIV docking-inhibi

A new approach for an HIV docking-inhibitor drug designed on the basis of the dual recognition/binding hypothesis between the CD4 receptor and the envelope glycoprotein of the HIV

✍ Zoltán Székely; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 673 KB

Design of a Gag Pentapeptide Analogue th

Design of a Gag Pentapeptide Analogue that Binds Human Cyclophilin A More Efficiently than the Entire Capsid Protein: New Insights for the Development of Novel Anti-HIV-1 Drugs†

✍ Li, Quan; Moutiez, Mireille; Charbonnier, Jean-Baptiste; Vaudry, Karine; Ménez, 📂 Article 📅 2000 🏛 American Chemical Society 🌐 English ⚖ 165 KB

Correlation between the predicted and th

Correlation between the predicted and the observed biological activity of the symmetric and nonsymmetric cyclic urea derivatives used as HIV-1 protease inhibitors. A 3D-QSAR-CoMFA method for new antiviral drug design

✍ Speranta Avram; I. Svab; C. Bologa; Maria-Luiza Flonta 📂 Article 📅 2003 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 588 KB

6 Kinase by-pass: A new strategy for ant

6 Kinase by-pass: A new strategy for antiviral drug discovery: C. McGuigan, R.N. Pathirana, P. Bellevergue and M. Davies [Dept. of Chemistry, University of Southampton, Southampton, UK], N. Mahmood [MRC Collaborative Centre, Mill Hill, UK] and A.J. Hay [National Institute for Medical Research, London, UK]

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 66 KB

New classes of reagents that attack cons

New classes of reagents that attack conserved and chemically reactive zinc fingers in retroviral nucleocapsid proteins: A strategy for rational drug design: W. G. Rice*, C. A. Schaeffer*, J. A. Turpin*, L. Coreff†, R. C. Sowder II†, B. Kane†, J. Bader, L. O. Arthur†, and L. E. Hertterson†: *Laboratory of Antiviral Drug Mechanisms and †AIDS Vaccine Program PRI/DynCorp, NCI-FCRDC, Frederick, MD, USA and Developmental Therapeutics Program, National Cancer Institute, Bettesda, MD USA

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 58 KB